Potential New Treatment Strategies for Prostate Cancer presented at ESMO 2014

Potential New Treatment Strategies for Prostate Cancer presented at ESMO 2014
Recent randomized phase III trials data presented at the European Society for Medical Oncology (ESMO) Meeting 2014, showed how patients with prostate cancer exhibit an increase in overall survival upon new treatment strategies. Androgen deprivation therapy (ADT) is currently the treatment of choice for patients with prostate cancer, both for high-risk non-metastatic and metastatic prostate cancer.

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *